Super catalytic antibody [I]: Decomposition of targeted protein by its antibody light chain

Journal of Bioscience and Bioengineering

Volumn 88, Issue 3, 1999, Pages 323-327

  Hifumi, Emi ^a   Okamoto, Yoshiko ^a   Uda, Taizo ^a  

^a PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

Author keywords

Gp41; HIV; Peptide; Super catalytic antibody

Indexed keywords

AMINO ACIDS; ANTIGEN-ANTIBODY REACTIONS; CATALYSIS; CHEMICAL BONDS; DECOMPOSITION; MOLECULAR STRUCTURE; PURIFICATION;

PEPTIDES; SUPER CATALYTIC ANTIBODY;

MONOCLONAL ANTIBODIES;

CATALYTIC ANTIBODY; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; CATALYSIS; CONTROLLED STUDY; DECOMPOSITION; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN TARGETING; VIRUS ENVELOPE;

EID: 0033200156     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-1723(00)80018-3     Document Type: Article

References (25)

1. 1. Zouali, M. and Hansen, D. E.: Antibodies - no longer just for binding. TIBTECH, 12, 73-74 (1994).
2. 2. Tramontano, A., Janda, K. D., and Lerner, R. A.: Catalytic antibodies. Science, 234, 1566-1570 (1986).
3. 3. Pollack, S. J., Jacobs, J. W., and Schultz, P. G.: Selective chemical catalysis by an antibody. Science, 234, 1570-1573 (1986).
4. 4. Iverson, B. L. and Lerner, R. A.: Sequence-specific peptide cleavage catalyzed by an antibody. Science, 243, 1184-1188 (1989).
5. 5. Cochran, A. G. and Schultz, P. G.: Antibody-catalyzed porphyrin metallation. Science, 249, 781-783 (1990).
6. 6. Miyashita, H., Karaki, Y., Kikuchi, M., and Fujii, I.: Prodrug activation via catalytic antibodies. Proc. Natl. Acad. Sci. USA, 90, 5337-5340 (1993).
7. 7. Thorn, S. N., Daniels, R. G., Auditor, M-T. M., and Hilvert, D.: Large rate accelerations in antibody catalysis by strategic use of haptenic charge. Nature, 373, 228-230 (1995).
8. 8. Paul, S., Volle, D. J., Beach, C. M., Johnson, D. R., Powell, M. J., and Massey, R. J.: Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science, 244, 1158-1162 (1989).
9. 9. Sun, M., Mody, B., Eklund, S. H., and Paul, S.: Vasoactive intestinal peptide hydrolysis by antibody light chains (Communication). J. Biol. Chem., 266, 15571-15574 (1991).
10. 10. Sun, M., Gao, Q. S., Li, L., and Paul, S.: Proteolytic activity of an antibody light chain. J. Immunology, 153, 5121-5126 (1994).
11. 11. Paul, S., Sun, M., Mody, R., Tewary, H. K., Stemmer, P., Massey, R. J., Gianferrara, T., Mehrotra, S., Dreyer, T., Meldal, M., and Tramontano, A.: Peptidolytic monoclonal antibody elicited by a neuropeptide (Communication). J. Biol. Chem., 267, 13142-13145 (1992).
12. 12. Gao, Q-S., Sun, M., Tyutyukova, S., Webster, D., Rees, A., Tramontano, A., Massey, R. J., and Paul, S.: Molecular cloning of a proteolytic antibody light chain. J. Biol. Chem., 269, 32389-32393 (1994).
13. 13. Erhan, S. and Greller, L. D.: Do immunogloblins have proteolytic activity? Nature, 251, 353-355 (1974).
14. 14. Paul, S., Li, L., Kalaga, R., Wilkins-Stevens, P., Stevens, F. J., and Solomom, A.: Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones protein and VL fragment. J. Biol. Chem., 270, 15257-15261 (1995).
15. 15. Matsuura, K. and Sinohara, H.: Catalytic cleavage of vasopressin by human Bence Jones proteins at the arginyglycinamide bond. Biol. Chem., 377, 587-589 (1996).
16. 16. Matsuura, K., Ikoma, S., Yoshida, K., and Shinohara, H.: DNA-hydrolyzing activity of Bence-Jones proteins. Biochem. Biophy. Res. Commun., 243, 719-721 (1998).
17. 17. Muesing, M. A., Smith, D. H., Cabradilla, C. D., Benton, C. D., Lasky, L. A., and Capon, D. J.: Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature, 313, 450-458 (1985).
18. 18. Kennedy, R. C., Henkel, R. D., Pauletti, D., Allan, J. S., Lee, T. H., Essex, M., and Dreesman, G. R.: Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science, 231, 1556-1559 (1986).
19. 19. Vella, C., Minor, P. D., Weller, I. V. D., Jenkins, O., Evans, D., and Almond, J.: Recognition of poliovirus/HIV chimaeras by antisera from individuals with HIV infection. J. Gen. Virol., 74, 2603-2607 (1993).
20. 20. Uda, T., Hifumi, E., Kobayashi, T., Kousuke, K., Sata, T., and Ogino, K.: An approach for an immunoaffinity AIDS sensor using the conservative region of the HIV envelope protein (gp41) and its monoclonal antibody. Biosensors & Bioelectronics, 10, 477-483 (1995).
21. 21. Uda, T., Hifumi, E., Okamoto, Y., Zhou, Y., and Ishimaru, M.: Destruction of gp41 of HIV-1 envelope by its catalytic antibody light chain. Clinical Science (The 12th World AIDS Conference, Geneva, Switzerland), 2, 429-433 (1998).
22. 22. Hifumi, E., Okamoto, Y., and Uda, T.: How and why 41S-2 antibody subunits acquire theactivities to catalyze decomposition of the conserved sequence of gp41 of HIV-1. Appl. Biochem. Biotech. (1999). (in press)
23. 23. Usagawa, T., Nishimura, M., Uda, T., and Nakahara, Y.: Preparation of monoclonal antibodies against methamphetamine. J. Immunol. Methods, 119, 111-115 (1989).
24. 24. Uda, T., Hifumi, E., Ishimaru, M., Morihara, F., Tadamura, K., and Itoh, T.: Analysis of the antigen recognition sites for anti methamphetamine monoclonal antibodies (I). J. Ferment. Bioeng., 83, 333-340 (1997).
25. 25. Takagi, M., Kohda, K., Hamuro, T., Harada, A., Yamaguchi, H., Kamachi, M., and Imanaka, T.: Thermostable peroxidase activity with a recombinant antibody L chain-porphyrin Fe(III) complex. FEBS Lett., 375, 273-276 (1995).